PDSB
PDS Biotechnology CorpCompany Information
- Company Name
- PDS Biotechnology Corp
- CIK
- CIK0001472091
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PDSB: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PDSB
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-02-28
- Last sale
- —
- Shares purchased (TTM)
- 30,121
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 7,681,568
- Shares outstanding
- 55,659,669
- Ownership
- 13.80%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -5.58%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 6 | 22 | 27 | 26 | 32 | 40 | 42 | 50 | 58 | 67 | 57 | 54 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 3 | ||||||
| Assets Current | 7 | 23 | 28 | 28 | 34 | 42 | 45 | 52 | 60 | 69 | 59 | 57 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Prepaid Expense Other Noncurrent | 2 | 2 | 2 | 7 | 7 | 4 | 0 | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 9 | 25 | 30 | 35 | 40 | 47 | 45 | 52 | 60 | 69 | 59 | 57 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 6 | 4 | 4 | 5 | 4 | 3 | 2 | 1 | 3 | 6 | 7 | 5 | ||||||
| Accrued Liabilities Current | 2 | 1 | 1 | 2 | 1 | 3 | 3 | 4 | 2 | 2 | 2 | 4 | ||||||
| Secured Debt Current | 4 | 5 | 5 | 6 | 6 | 13 | 13 | 13 | 10 | 7 | 4 | - | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 12 | 10 | 9 | 13 | 12 | 18 | 17 | 18 | 16 | 15 | 14 | 9 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Secured Long Term Debt | 0 | 11 | 12 | 12 | 13 | 6 | 9 | 12 | 14 | 17 | 20 | 23 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 12 | 21 | 21 | 25 | 25 | 25 | 26 | 30 | 30 | 32 | 33 | 33 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 230 | 228 | 226 | 218 | 216 | 213 | 201 | 196 | 194 | 192 | 171 | 158 | ||||||
| Retained Earnings Accumulated Deficit | -234 | -224 | -217 | -209 | -200 | -191 | -182 | -174 | -163 | -155 | -145 | -134 | ||||||
| Stockholders Equity | -4 | 4 | 9 | 9 | 16 | 22 | 19 | 22 | 31 | 37 | 26 | 24 | ||||||
| Liabilities And Stockholders Equity | 9 | 25 | 30 | 35 | 40 | 47 | 45 | 52 | 60 | 69 | 59 | 57 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 75 | 75 | 75 | ||||||
| Common Stock Shares Issued | 56 | 56 | 55 | 48 | 47 | 45 | 38 | 37 | 37 | 37 | 33 | 31 | ||||||
| Shares Outstanding | 56 | 56 | 55 | 48 | 47 | 45 | 38 | 37 | 37 | 37 | 33 | 31 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPDS Biotechnology Corp (PDSB) — SEC Financial Statements & Analysis
PDS Biotechnology Corp (PDSB) is a pharmaceutical preparations company, incorporated in DE. PDS Biotechnology Corp trades on Nasdaq as: PDSB. PDS Biotechnology Corp (PDSB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, PDS Biotechnology Corp carries a market cap of $49.04M, a P/E ratio of -1.46x, a P/B ratio of -13.70x, an enterprise value of $47.80M, and an EV/EBITDA multiple of -1.72x. On profitability, it posts a Return on Equity (ROE) of -543.97%, a Return on Assets (ROA) of -136.65%, and a Return on Invested Capital (ROIC) of -36933.69%. Per share, it reports EPS of $-0.60, diluted EPS of $-0.60, free cash flow per share of $-0.30, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -8.01% year-over-year and EPS growth of -24.13% year-over-year. On the balance sheet, it maintains a current ratio of 0.57x, a quick ratio of 0.45x, working capital of $-5.33M, a debt-to-equity ratio of -3.46x, a debt ratio of 1.41, an interest coverage ratio of -4.18x, free cash flow of $-16.78M (TTM), and net debt of $-1.23M. Figures sourced from SEC EDGAR.
- Market Cap
- $49.04M
- P/E TTM
- -1.46x
- EPS TTM
- $-0.60
- P/B TTM
- -13.70x
- ROE TTM
- -543.97%
- ROA TTM
- -136.65%
- Debt To Equity
- -3.46x
- Free Cash Flow TTM
- $-16.78M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PDS Biotechnology Corp in?
PDS Biotechnology Corp (PDSB) operates in the Pharmaceutical Preparations industry.
What exchange does PDSB trade on?
PDS Biotechnology Corp (PDSB) trades on the Nasdaq.
Where is PDS Biotechnology Corp incorporated?
PDS Biotechnology Corp is incorporated in DE.
When was PDS Biotechnology Corp (PDSB)'s most recent SEC filing?
PDS Biotechnology Corp (PDSB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is PDSB's market cap?
PDS Biotechnology Corp (PDSB) has a market capitalization of $49.04M as of 2026-06-30.
What is PDSB's EPS (earnings per share)?
PDS Biotechnology Corp (PDSB)'s trailing twelve month EPS is $-0.60 as of 2026-06-30.
What is PDSB's ROE (return on equity)?
PDS Biotechnology Corp (PDSB)'s trailing twelve month Return on Equity (ROE) is -543.97% as of 2026-06-30.
What is PDSB's ROA (return on assets)?
PDS Biotechnology Corp (PDSB)'s trailing twelve month Return on Assets (ROA) is -136.65% as of 2026-06-30.
What is PDSB's ROIC (return on invested capital)?
PDS Biotechnology Corp (PDSB)'s trailing twelve month Return on Invested Capital (ROIC) is -36933.69% as of 2025-06-30.
What is PDSB's EV/EBITDA?
PDS Biotechnology Corp (PDSB)'s trailing twelve month EV/EBITDA is -1.72x as of 2026-06-30.